Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Alx Oncology Holdings Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 85 | 61 | −24 |
| Shares | 34.8M | 29.1M | −5.73M (−16.5%) |
| Value | $21.7M | $12.1M | −$9.59M (−44.3%) |
New holders (10)
Institutions that held Alx Oncology Holdings Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 203,266 | $84.4K | 0.00% |
| Gsa Capital Partners LLP | 81,326 | $34.0K | 0.00% |
| Squarepoint Ops LLC | 58,307 | $24.2K | 0.00% |
| Nan Fung Trinity (HK) Ltd | 41,950 | $17.4K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 27,709 | $11.5K | 0.00% |
| Callan Family Office, LLC | 19,778 | $8.21K | 0.00% |
| Abel Hall, LLC | 15,209 | $6.31K | 0.00% |
| Raymond James Financial Inc | 1,000 | $415 | 0.00% |
| Clearstead Advisors, LLC | 177 | $74 | 0.00% |
| True Wealth Design, LLC | 15 | $7 | 0.00% |
Sold out (34)
Institutions that held Alx Oncology Holdings Inc at the end of Q1 2025 and filed for Q2 2025 without it.